Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data.

Lisa M McShane1, Michael D Radmacher, Boris Freidlin

  • 1National Cancer Institute, Biometric Research Branch, DCTD, NIH, Bethesda, MD 20892-7434, USA. lm5h@nih.gov

Bioinformatics (Oxford, England)
|November 9, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum microRNA Profiles Reflect Differentiation Status and Age in Early Gastric Cancer.

Biomolecules·2026
Same author

Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I.

JCO precision oncology·2026
Same author

Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E.

JCO precision oncology·2026
Same author

Changing standard of care during a randomized trial: examples, considerations and guidelines.

Journal of the National Cancer Institute·2026
Same author

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i><sup><i>V600E</i></sup> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H.

JCO precision oncology·2026

This study introduces new statistical methods to validate clusters found in gene expression profiles from cDNA microarray data. These methods objectively measure cluster reproducibility, aiding in the interpretation of biological specimen groupings.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • cDNA microarray technology enables simultaneous interrogation of thousands of genes, generating gene expression profiles.
  • Discovering novel specimen subgroups (clusters) based on these profiles is crucial for applications like tumor taxonomy.
  • Existing clustering techniques can identify patterns but lack objective measures for result reproducibility.

Purpose of the Study:

  • To develop and present statistical methods for assessing the overall clustering of gene expression profiles.
  • To define interpretable measures for evaluating cluster-specific reproducibility.
  • To enhance the understanding of clustering structures within microarray data.

Main Methods:

  • Statistical methods for testing overall clustering.

Related Experiment Videos

  • Development of cluster-specific reproducibility measures.
  • Application to cDNA microarray gene expression data.

    • Main Results:

    • The study presents novel statistical methods for cluster validation in gene expression data.
    • Introduced interpretable measures quantify cluster reproducibility.
    • Methods were successfully applied to melanoma and prostate specimen data.

    Conclusions:

    • The presented statistical methods provide objective measures for validating clusters in gene expression profiles.
    • These methods facilitate a more reliable interpretation of specimen subgroupings derived from microarray data.
    • Improved understanding of biological structures within complex datasets like tumor taxonomies.